As sorafenib was reported to stabilize PINK1 on the OMM to target and inhibit the electron transport chain in mitochondria, and activate the recruitment of Parkin by mitochondria to start mitophagy to treat liver cancer.154. This evidence concerns the gene PRKN and liver cancer.